With the onset of the COVID-19 pandemic in the U.S. in early March, the better portion of 2020 has been devoted to adjusting to the ?��new normal.?�� Although expectations are high that a vaccine will be readily available by the year?'s end, the situation is complex and defies a neat solution.
